# LHX6

## Overview
LHX6 is a gene that encodes the LIM homeobox 6 protein, a transcription factor characterized by the presence of two LIM domains and a homeodomain. This protein plays a pivotal role in the development and differentiation of neural cells, particularly in the specification and migration of GABAergic interneurons within the central nervous system (Alifragis2004Lhx6; Zhao2008Distinct). The LIM domains facilitate protein-protein interactions, while the homeodomain is essential for DNA binding, allowing LHX6 to regulate the expression of target genes involved in neural development (zhang2002comparison; Srivastava2010Early). LHX6 is also implicated in various biological processes beyond neural development, including its role as a tumor suppressor in certain cancers and its involvement in craniofacial and dental development (Zhang2013The; Yang2017LHX6). The gene's expression and function are tightly regulated, with alterations in its activity linked to significant clinical outcomes (He2021Lhx6; Nathalia2018Downregulation).

## Structure
LHX6 (LIM homeobox 6) is a transcription factor characterized by the presence of two LIM domains and a homeodomain. These domains are crucial for its function in DNA binding and protein-protein interactions. The LIM domains are zinc-binding motifs that contribute to the protein's tertiary structure, facilitating interactions with other nuclear proteins to regulate gene expression (zhang2002comparison; Srivastava2010Early). The homeodomain is responsible for binding to specific DNA sequences, playing a key role in the regulation of target genes involved in neural development (Srivastava2010Early).

The Lhx6 gene is known to produce different splice variant isoforms, which may have distinct functions in various biological processes (Srivastava2010Early). Although specific post-translational modifications of LHX6 are not detailed in the provided context, such modifications, like phosphorylation, could influence the protein's activity and stability, as is common with transcription factors (Srivastava2010Early).

The molecular structure of LHX6, including its LIM and homeodomains, is integral to its role in the development and differentiation of neural cells, particularly in the migration and specification of interneurons in the central nervous system (Alifragis2004Lhx6; Zhao2008Distinct).

## Function
LHX6 is a transcription factor crucial for the development and differentiation of specific interneuron subtypes in the brain, particularly GABAergic interneurons. It plays a significant role in the specification of parvalbumin (PV) and somatostatin (SST) interneurons, which are essential for maintaining inhibitory control within neural circuits (Liodis2007Lhx6Activity; CruzSantos2022A). LHX6 is expressed in the medial ganglionic eminence (MGE) and is involved in the tangential migration of interneurons from the MGE to the cortex, a process critical for proper cortical development (Alifragis2004Lhx6; Zhao2008Distinct).

The gene functions downstream of the NKX2.1 transcription factor, which activates LHX6 to specify the fate of PV and SST interneurons (Du2008NKX2.1). LHX6 influences the expression of several receptors and transcription factors, such as ErbB4, CXCR4, and CXCR7, which are involved in interneuron migration and differentiation (Zhao2008Distinct). It also affects the morphological characteristics of interneurons, promoting a non-spiny morphology typical of cortical interneurons (Du2008NKX2.1). LHX6's activity is crucial for establishing functional interneuron circuits, impacting neural circuitry and synaptic function in the brain (Liodis2007Lhx6Activity).

## Clinical Significance
LHX6 is implicated in various cancers, particularly lung adenocarcinoma, where its expression is often downregulated due to hypermethylation. This downregulation is associated with poor prognostic outcomes, as low LHX6 expression correlates with reduced overall survival in lung adenocarcinoma patients (Nathalia2018Downregulation; Yang2017LHX6). LHX6 acts as a tumor suppressor by inhibiting cell proliferation, migration, and invasion, and its silencing can lead to enhanced tumorigenesis and metastasis (Wang2020&lt; Liu2013LHX6; p&gt; LHX6). The gene's tumor-suppressive effects are partly mediated through the transcriptional silencing of the Wnt/β-catenin signaling pathway, which is crucial in cancer progression (Yang2017LHX6).

In addition to its role in cancer, LHX6 is involved in craniofacial and dental development. Mutations or altered expression of LHX6 can lead to developmental anomalies, such as craniofacial defects, due to its interaction with the PITX2 transcription factor (Zhang2013The). These findings highlight the clinical significance of LHX6 in both oncological and developmental contexts.

## Interactions
LHX6, a LIM homeobox transcription factor, is involved in various protein interactions that influence its role in cellular processes. One significant interaction is with MTG8, a transcriptional co-factor. MTG8 and LHX6 physically interact, as demonstrated by co-immunoprecipitation experiments, which show that MTG8 co-precipitates with LHX6. This interaction is independent of the LIM domains of LHX6 and does not involve the LIM-domain binding factor LDB1 (Asgarian2022MTG8). The interaction between MTG8 and LHX6 is crucial for the specification of cortical interneuron subtypes, particularly SST-NPY interneurons. MTG8 may stabilize LHX6 on target DNA, enhancing its activity, although MTG8 itself lacks intrinsic DNA binding capacity (Asgarian2022MTG8).

In the context of cancer, LHX6 interacts with the Wnt/β-catenin signaling pathway. LHX6 expression inversely correlates with β-catenin levels, suggesting that LHX6 may suppress Wnt/β-catenin signaling. This interaction affects erlotinib resistance and cell migration in EGFR-mutant non-small-cell lung cancer cells (Wang2020&lt; p&gt; LHX6). LHX6's role in regulating the Wnt signaling pathway is also evident in tooth development, where it modulates the differentiation of mesenchymal progenitor cells by interacting with Wnt antagonists like Sfrp2 (He2021Lhx6).


## References


[1. (Zhang2013The) Zichao Zhang, Diana Gutierrez, Xiao Li, Felicitas Bidlack, Huojun Cao, Jianbo Wang, Kelsey Andrade, Henry C. Margolis, and Brad A. Amendt. The lim homeodomain transcription factor lhx6. Journal of Biological Chemistry, 288(4):2485–2500, January 2013. URL: http://dx.doi.org/10.1074/jbc.m112.402933, doi:10.1074/jbc.m112.402933. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.402933)

[2. (Nathalia2018Downregulation) Evelyn Nathalia, Madelaine Skolastika Theardy, Sharleen Elvira, Graciella Rosellinny, Andrew Steven Liyanto, Michael Putra Utama, and Anton Sumarpo. Downregulation of tumor-suppressor gene lhx6 in cancer: a systematic review. Romanian Journal of Internal Medicine, 56(3):135–142, August 2018. URL: http://dx.doi.org/10.2478/rjim-2018-0008, doi:10.2478/rjim-2018-0008. This article has 3 citations.](https://doi.org/10.2478/rjim-2018-0008)

[3. (Alifragis2004Lhx6) Pavlos Alifragis, Anastasia Liapi, and John G. Parnavelas. Lhx6 regulates the migration of cortical interneurons from the ventral telencephalon but does not specify their gaba phenotype. The Journal of Neuroscience, 24(24):5643–5648, June 2004. URL: http://dx.doi.org/10.1523/JNEUROSCI.1245-04.2004, doi:10.1523/jneurosci.1245-04.2004. This article has 181 citations.](https://doi.org/10.1523/JNEUROSCI.1245-04.2004)

[4. (Du2008NKX2.1) Tonggong Du, Qing Xu, Polloneal J. Ocbina, and Stewart A. Anderson. Nkx2.1 specifies cortical interneuron fate by activatinglhx6. Development, 135(8):1559–1567, April 2008. URL: http://dx.doi.org/10.1242/dev.015123, doi:10.1242/dev.015123. This article has 185 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.015123)

[5. (Zhao2008Distinct) Yangu Zhao, Pierre Flandin, Jason E. Long, Melissa Dela Cuesta, Heiner Westphal, and John L.R. Rubenstein. Distinct molecular pathways for development of telencephalic interneuron subtypes revealed through analysis of lhx6 mutants. Journal of Comparative Neurology, 510(1):79–99, July 2008. URL: http://dx.doi.org/10.1002/cne.21772, doi:10.1002/cne.21772. This article has 183 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.21772)

[6. (Liu2013LHX6) W-b Liu, X Jiang, F Han, Y-h Li, H-q Chen, Y Liu, J Cao, and J-y Liu. Lhx6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Cell Death &amp; Disease, 4(10):e882–e882, October 2013. URL: http://dx.doi.org/10.1038/cddis.2013.366, doi:10.1038/cddis.2013.366. This article has 46 citations.](https://doi.org/10.1038/cddis.2013.366)

[7. (Yang2017LHX6) Juntang Yang, Fei Han, Wenbin Liu, Mingqian Zhang, Yongsheng Huang, Xianglin Hao, Xiao Jiang, Li Yin, Hongqiang Chen, Jia Cao, Huidong Zhang, and Jinyi Liu. Lhx6, an independent prognostic factor, inhibits lung adenocarcinoma progression through transcriptional silencing of β-catenin. Journal of Cancer, 8(13):2561–2574, 2017. URL: http://dx.doi.org/10.7150/jca.19972, doi:10.7150/jca.19972. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.19972)

[8. (Asgarian2022MTG8) Zeinab Asgarian, Marcio Guiomar Oliveira, Agata Stryjewska, Ioannis Maragkos, Anna Noren Rubin, Lorenza Magno, Vassilis Pachnis, Mohammadmersad Ghorbani, Scott Wayne Hiebert, Myrto Denaxa, and Nicoletta Kessaris. Mtg8 interacts with lhx6 to specify cortical interneuron subtype identity. Nature Communications, September 2022. URL: http://dx.doi.org/10.1038/s41467-022-32898-6, doi:10.1038/s41467-022-32898-6. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-32898-6)

[9. (CruzSantos2022A) Maria Cruz-Santos, Lucia Fernandez Cardo, and Meng Li. A novel lhx6 reporter cell line for tracking human ipsc-derived cortical interneurons. Cells, 11(5):853, March 2022. URL: http://dx.doi.org/10.3390/cells11050853, doi:10.3390/cells11050853. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells11050853)

[10. (Liodis2007Lhx6Activity) Petros Liodis, Myrto Denaxa, Marirena Grigoriou, Cynthia Akufo-Addo, Yuchio Yanagawa, and Vassilis Pachnis. Lhx6activity is required for the normal migration and specification of cortical interneuron subtypes. The Journal of Neuroscience, 27(12):3078–3089, March 2007. URL: http://dx.doi.org/10.1523/jneurosci.3055-06.2007, doi:10.1523/jneurosci.3055-06.2007. This article has 324 citations.](https://doi.org/10.1523/jneurosci.3055-06.2007)

[11. (Srivastava2010Early) Mansi Srivastava, Claire Larroux, Daniel R Lu, Kareshma Mohanty, Jarrod Chapman, Bernard M Degnan, and Daniel S Rokhsar. Early evolution of the lim homeobox gene family. BMC Biology, January 2010. URL: http://dx.doi.org/10.1186/1741-7007-8-4, doi:10.1186/1741-7007-8-4. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/1741-7007-8-4)

[12. (He2021Lhx6) Jinzhi He, Junjun Jing, Jifan Feng, Xia Han, Yuan Yuan, Tingwei Guo, Fei Pei, Yuanyuan Ma, Courtney Cho, Thach-Vu Ho, and Yang Chai. Lhx6 regulates canonical wnt signaling to control the fate of mesenchymal progenitor cells during mouse molar root patterning. PLOS Genetics, 17(2):e1009320, February 2021. URL: http://dx.doi.org/10.1371/journal.pgen.1009320, doi:10.1371/journal.pgen.1009320. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1009320)

13. (zhang2002comparison) Y Zhang, T Mori, H Takaki, M Takeuchi, K Iseki, S Hagino, M Murakawa, S Yokoya, and A Wanaka. Comparison of the expression patterns of two lim-homeodomain genes, lhx6 and l3/lhx8, in the developing palate. Orthodontics & craniofacial research, 5(2):65–70, 2002. This article has 34 citations.